Free standard shipping on orders $300+ · Same-day dispatch before 2PM AEST
AUSTRALIAN OWNED & OPERATED
FAST DISCREET SHIPPING AUSTRALIA WIDE
LAB TESTED FOR PURITY & QUALITY
Customer Support:
contact@aussiepeptideco.com
Packaging Notice: Vial label design and print may vary between batches. Product specifications remain unchanged.
Metabolic Research

Semaglutide

GLP-1 receptor agonist

Be the first to review SKU: APC-SEMAGLUTIDE-20MG
Purity≥99.0% by HPLC
Independently TestedThird-Party Analysis
Batch-Specific COAAvailable for This Batch
$200.00 AUD
In Stock
Strength
Quantity
Order before 2PM AEST for same-day dispatch.

Related Laboratory Supplies

Essential items for laboratory research and sample preparation.

Third-Party Tested

HPLC Purity & Mass Spec Identity

Batch-Specific COA

Certificate for Each Batch

Discreet Packaging

Plain, Unbranded & Tamper-Evident

Same-Day Dispatch

Order Before 2PM AEST, Australia-Wide

Semaglutide is a synthetic peptide that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. It is studied for its effects on metabolic signalling, glucose regulation and receptor-mediated cellular responses. Semaglutide Australia research includes investigations into incretin pathways and metabolic function using controlled experimental models.

The Semaglutide material described on this page is intended strictly for laboratory and in-vitro research. It is not supplied for human or veterinary use.

What Is Semaglutide?

Semaglutide is a modified peptide based on the structure of human GLP-1, a naturally occurring incretin hormone involved in metabolic regulation.

It binds to and activates the GLP-1 receptor, a G protein-coupled receptor involved in glucose-dependent insulin signalling and other metabolic processes.

Semaglutide contains structural modifications that increase its resistance to enzymatic breakdown and extend its activity compared with native GLP-1.

The active pharmaceutical ingredient is used in registered medicines, including Ozempic and Wegovy. However, independently supplied Semaglutide research material is separate from these approved pharmaceutical products. It should not be considered therapeutically equivalent or suitable for clinical use.

Semaglutide in Metabolic Research

Semaglutide has been investigated in laboratory, preclinical and clinical research involving several aspects of metabolic function.

Research areas include:

  • Glucose-dependent cellular signalling
  • GLP-1 receptor activation and downstream pathways
  • Incretin-related metabolic regulation
  • Pancreatic beta-cell signalling
  • Receptor interactions in experimental metabolic models

Laboratory studies may examine receptor binding, cAMP production and other measurable cellular responses.

Published clinical studies provide information about pharmaceutical Semaglutide under controlled medical conditions. Those findings do not establish the safety, effectiveness or suitability of independently supplied research material.

Quick Product Information

Specification Details
Product name Semaglutide
Research classification Synthetic GLP-1 receptor agonist
Research target GLP-1 receptor (GLP-1R)
Molecular formula C₁₈₇H₂₉₁N₄₅O₅₉
Molecular weight Approximately 4,113.58 g/mol
CAS number 910463-68-2
Physical form Lyophilised powder, subject to product specification
Available strengths 5mg, 10mg and 20mg
Purity Refer to verified batch-specific CoA
Analytical testing methods HPLC and MS/LC-MS, where documented
Certificate of Analysis Batch-specific documentation, where available
Storage requirements Follow verified batch-specific storage instructions
Intended use Laboratory and in-vitro research only

How Semaglutide Works in Research

GLP-1 Receptor Activity

Semaglutide interacts with GLP-1 receptors found in several tissues involved in metabolic regulation.

GLP-1 receptor activation stimulates intracellular signalling pathways, particularly those involving cyclic adenosine monophosphate (cAMP).

In suitable experimental models, these pathways can influence glucose-dependent insulin secretion, cellular responses and metabolic signalling.

Researchers examine these interactions to understand how GLP-1 receptor activation affects different biological systems.

Receptor Signalling and Molecular Stability

Native GLP-1 is rapidly degraded by enzymes, including dipeptidyl peptidase-4 (DPP-4).

Semaglutide has structural modifications that reduce enzymatic degradation and promote albumin binding, extending its activity.

These characteristics make it useful for investigating sustained GLP-1 receptor signalling under defined experimental conditions.

Semaglutide vs Other Incretin Research Peptides

Semaglutide, Tirzepatide and Retatrutide are investigated for their interactions with receptors involved in metabolic regulation.

Compound Receptor activity
Semaglutide GLP-1
Tirzepatide GIP + GLP-1
Retatrutide GIP + GLP-1 + Glucagon

Semaglutide targets the GLP-1 receptor, while Tirzepatide activates two incretin receptors. Retatrutide also includes glucagon receptor activity.

These differences are relevant when selecting receptor pathways for experimental investigation.

Semaglutide Research in Australia

Semaglutide is an established pharmaceutical ingredient, with certain Semaglutide medicines registered by Australia’s Therapeutic Goods Administration (TGA).

This regulatory status does not extend automatically to independently supplied laboratory research peptides.

Australian researchers should consider applicable TGA requirements, institutional procedures and relevant laboratory regulations when handling research compounds.

Clear product identification, batch traceability and supporting analytical documentation are important for research records.

A research-only designation does not itself establish regulatory exemption or authorise human use.

This product is intended strictly for laboratory and in-vitro research purposes. It has not been evaluated for human or veterinary use, and any information provided here is for educational reference only.

Specifications

Product NameSemaglutide 20mg
ManufacturerZynova Labs
Strength20mg
Molecular FormulaC₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight4,113.58 g/mol
Purity≥99.0% (HPLC, batch ZL-26-20)
CAS No.910463-68-2
FormLyophilised powder, subject to product specification
StorageFollow verified batch-specific storage instructions
Research CategoryMetabolic Research
TestingIndependent third-party HPLC & MS
DocumentationBatch-specific COA included
UsageFor Research Use Only. Not for human consumption.

Certificate of Analysis

Quality, Purity and Batch Testing

Analytical testing helps researchers assess the identity and composition of Semaglutide material.

High-Performance Liquid Chromatography (HPLC) can be used to assess chromatographic purity and detect certain impurities.

Mass Spectrometry (MS), including LC-MS, can help confirm molecular mass and support compound identification.

A batch-specific Certificate of Analysis (CoA) should identify the material, batch number, testing methods and reported results.

Purity values should only be stated when supported by actual testing documentation.

Analytical purity does not confirm sterility, absence of endotoxins, clinical safety or suitability for administration.

CERTIFICATE OF ANALYSIS
Semaglutide 20mg
Batch: ZL-26-20 · 12/06/2026
Janoshik Analytical Certificate of Analysis for Semaglutide 20mg

Storage & Handling

Storage and Laboratory Handling

Semaglutide research material should be stored according to the verified conditions provided in its batch documentation.

Laboratories should manage temperature exposure, moisture, light and vial integrity where these factors may affect sample stability.

Appropriate contamination controls and laboratory standard operating procedures should be followed.

Storage duration and conditions after reconstitution should not be assumed without supporting stability data.

Research Use Only: For Research Use Only. Not for human or veterinary use. This material is intended strictly for laboratory and in-vitro research purposes and must not be consumed or administered.

Unopened VialFollow verified batch-specific storage instructions
HandlingUse appropriate PPE and standard laboratory safety procedures
ShippingTracked, discreet delivery Australia-wide via Australia Post. Express available.

Reconstitution calculator: Semaglutide 20mg

Work out concentration and the volume to draw for each aliquot before you add diluent.

mg
mL
Concentration
–
Volume per aliquot
–
On a 1 mL (U-100) syringe
–
Aliquots per vial
–

A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.

For Research Use Only. Not for human or veterinary consumption.

Semaglutide Frequently Asked Questions

Semaglutide is a synthetic GLP-1 analogue investigated for its effects on incretin signalling and metabolic regulation. It activates GLP-1 receptors involved in glucose-dependent cellular responses.

Semaglutide is a modified, long-acting GLP-1 receptor agonist. Its molecular structure includes amino acid substitutions and a fatty acid modification that influence enzymatic stability and albumin binding.

Semaglutide primarily targets the GLP-1 receptor. Activation of this receptor triggers intracellular signalling pathways involved in metabolic regulation, including cAMP-mediated responses in suitable experimental systems.

Semaglutide acts on GLP-1 receptors, whereas Tirzepatide activates both GIP and GLP-1 receptors. This distinction allows researchers to investigate different incretin signalling mechanisms.

Semaglutide is a single-receptor agonist. Retatrutide activates GLP-1, GIP and glucagon receptors, making its receptor activity broader and relevant to different experimental research questions.

Researchers investigate Semaglutide to understand GLP-1 receptor signalling, glucose-dependent cellular responses and metabolic pathway regulation. Studies include receptor-based assays, cellular models and preclinical experiments.

Semaglutide has the molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and a molecular weight of approximately 4,113.58 g/mol. Its CAS registry number is 910463-68-2.

HPLC can assess chromatographic purity and identify certain impurities. Mass spectrometry supports molecular identity verification. Results should be evaluated against the analytical methods documented for each batch.

A CoA should identify the compound, batch number, analytical methods, test results and relevant specifications. Supporting chromatograms or mass spectra may also be included where available.

No. This material is designated exclusively for laboratory and in-vitro research. It is not an approved medicine and must not be consumed, administered or used for human or veterinary treatment.

No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.

Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.

Reviews

There are no reviews yet.

Be the first to review “Semaglutide”

Your email address will not be published. Required fields are marked *

Shopping Cart (0 items)

Your cart is empty

Add some research compounds to get started.

Browse Products